- Home
- TOVX vs SHPH Comparison
TOVX vs SHPH Comparison
Compare TOVX & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- SHPH
- Stock Information
- Founded
- TOVX 2001
- SHPH 2012
- Country
- TOVX United States
- SHPH United States
- Employees
- TOVX N/A
- SHPH N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- TOVX Health Care
- SHPH Health Care
- Exchange
- TOVX Nasdaq
- SHPH Nasdaq
- Market Cap
- TOVX 3.2M
- SHPH 3.2M
- IPO Year
- TOVX 2006
- SHPH 2022
- Fundamental
- Price
- TOVX $1.48
- SHPH $0.84
- Analyst Decision
- TOVX Strong Buy
- SHPH
- Analyst Count
- TOVX 1
- SHPH 0
- Target Price
- TOVX $6.00
- SHPH N/A
- AVG Volume (30 Days)
- TOVX 1.2M
- SHPH 115.9K
- Earning Date
- TOVX 11-12-2024
- SHPH 11-13-2024
- Dividend Yield
- TOVX N/A
- SHPH N/A
- EPS Growth
- TOVX N/A
- SHPH N/A
- EPS
- TOVX N/A
- SHPH N/A
- Revenue
- TOVX N/A
- SHPH N/A
- Revenue This Year
- TOVX N/A
- SHPH N/A
- Revenue Next Year
- TOVX N/A
- SHPH N/A
- P/E Ratio
- TOVX N/A
- SHPH N/A
- Revenue Growth
- TOVX N/A
- SHPH N/A
- 52 Week Low
- TOVX $1.14
- SHPH $0.58
- 52 Week High
- TOVX $17.00
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- TOVX 49.48
- SHPH 49.54
- Support Level
- TOVX $1.42
- SHPH $0.83
- Resistance Level
- TOVX $2.03
- SHPH $0.92
- Average True Range (ATR)
- TOVX 0.17
- SHPH 0.08
- MACD
- TOVX -0.01
- SHPH 0.01
- Stochastic Oscillator
- TOVX 12.70
- SHPH 51.97
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.